An oxygen concentrator is a device used to deliver concentrated oxygen to a patient requiring oxygen therapy. These devices are considered as a safer, easy to use and inexpensive compared to compressed oxygen cylinders. Portable oxygen concentrator acts by increasing the concentration of oxygen by taking a mixture air from its surrounding. Major factors expected to drive the market for oxygen concentrators include its ability to provide oxygen under all circumstances and worldwide aging population coupled with COPD and other respiratory diseases.
The older versions of the oxygen concentrators were considered to be unreliable and difficult to use as they were bulky and costly. Over the past years, oxygen concentrators have been evolved as manufacturers are improving the design of them and by manufacturing them with a relatively smaller size & higher mobility. The market for oxygen concentrators has undergone significant changes and improvement with the introduction of portable technology. The devices have become lighter, more powerful and affordable leading to increasing demand in the homecare department. Increasing worldwide geriatric population means rise in homecare oxygen treatment. People with respiratory conditions such as chronic obstructive pulmonary disease (COPD), chronic bronchitis and emphysema have benefitted greatly with innovations in oxygen concentrator technology. Some of the new and improved versions of the standard large and bulky devices include AirSep’s Lifestyle portable oxygen concentrator, Inogen One G3, VBOX Trooper, EverGo, Invacare XPO2 and iGo. Browse Details of the Report @ https://www.hexaresearch.com/research-report/oxygen-concentrator-market The demand for lighter technology by consumers and need for better mobility support for the aged rises, new competitors enter the market thereby driving innovations. This has resulted in high-quality devices at lower prices. The global oxygen concentrator market is segmented by types, application and geography. On the basis of types, the global oxygen concentrator market is segmented into portable oxygen concentrator, stationary oxygen concentrator and so on. On the basis of application, the global oxygen concentrator market is segmented into medical, water treatment, pharmaceutical production, glass manufacture and so on. On the basis of geography, the global oxygen concentrator market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Asia Pacific Excluding Japan oxygen concentrators market is projected to register a significant CAGR during the forecast period. Improving economic conditions is fuelling the growth of the global oxygen concentrators market in Asia Pacific. The U.S. accounts for the largest share of the global oxygen concentrator market followed by Europe, due to growing consumer awareness rising incidences of COPD and demographic changes. COPD is known to be the fourth leading cause of death in the U.S. and the number has been dangerously rising, increasing the use of respiratory care devices. The change in lifestyle across the globe has led to an alarming rise in smoking population which has also fuelled the growth of the oxygen concentrator market. The key players of global oxygen concentrator market are Braun and Company, Air Liquide, CareFusion, Chart Industries, Covidien, DeVilbiss Healthcare, Drive Medical, Fanem, Fisher & Paykel Healthcare, Bio-Med Devices, Invacare Philips Healthcare, Jiangxi Teli Anesthesia, Respiration Equipment, Newport Medical Instruments Inc., Respironics, Providence Global Medical, Percussionaire Corporation, Vortran Medical Technology, Intersurgical Ltd., Smiths Medical WinterGreen Research Inc., Eget Hi-Tec Co. Ltd., Race Medical and Beauty Equipments and Maquet. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ Visit Our Blog - https://hexaresearchinc.wordpress.com/
0 Comments
Global Gastroscope Market Share, Size, Analysis, Trends, Growth and Forecast to 2021| Hexa Research5/23/2017 Gastroscopy (also known as an upper GI endoscopy) is a procedure that enables a gastroenterologist to examine the lining of the upper part of your gastrointestinal tract, i.e. the esophagus (swallowing tube), stomach, and duodenum (first portion of the small intestine) using a thin flexible tube that has a camera lens and light source.
Gastrointestinal Endoscope is a device or an instrument that allows a doctor or surgeon to look inside the body through existing openings or through small incisions. These instruments are used for inspecting the internal lining of the gastrointestinal tract. They help in detecting the cause of abdominal bleeding, any persistent pain, vomiting, tumor affecting the GI tract, inflation, etc. Any infections or abnormalities in function of this GI tract are detected by means of gastrointestinal endoscopic devices. Gastroscopy is more accurate than X-Ray films for detecting inflammation, ulcers, or tumors of the esophagus, stomach, and duodenum. Biopsies (small tissue samples) may be taken at the time of your gastroscopy. The instrument used is called Gastroscope, a flexible tube with a diameter less than that of a little finger. The gastroscope has light and a camera at the end. The camera sends pictures of the lining of your esophagus, stomach, and duodenum to a screen, where the endoscopist is able to look at them. All through the examination, the endoscopist may need to take some small tissues samples, called biopsies, for analysis under a microscope in lab. Browse Details of Report@ https://www.hexaresearch.com/research-report/gastroscope-market Gastrointestinal endoscopy is an industry driven by quickly evolving technology, an aging population all through the globe, and the augmented recognition of problems associated with morbid obesity that can sometimes be addressed by relatively noninvasive or minimally invasive actions. There are many drivers for this market, counting the evolution of technology so that many endoscopic-related diagnostic procedures are noninvasive, and the growing requirements by employer-based and government-funded health insurance companies for covered insurance members. The endoscope is a metal tube that has a small light source and camera at one end and an eyepiece at the other. Endoscopes may be made from an inflexible tube or, additional often, from a flexible tube that allows the surgeon to generously move and regulate it as it enters the area that is being observed. Upgraded designs of the equipment have also made flexible GI endoscopes easier to handle, and smaller instrumentation has permitted for more dedicated devices. As such kind of developments take place in the market; they will drive growth in unit sales, which will drive growth in the market value. Global Gastrointestinal Endoscope Market is segmented by Segment (Colonoscopy, Gastroscope, Duodenoscope and Eosophagoscopes). Global Gastrointestinal Endoscope Market is segmented By Type (Rigid and Flexible endoscopes [Video and Non-Video Endoscopes]). Global Gastroscope Market is segmented By Symptoms into Gastroscopy Persistent heartburn, Bleeding, Nausea and Vomiting, Pain, Problems Swallowing, Unexplained weight loss. Global Gastroscope Market is segmented By Geographical Region into North America, China, Europe, Japan, India, and Southeast Asia. Increased demand for advanced endoscopy devices is coming from emerging markets like Japan and Vietnam. The other countries like India, China, Brazil, and Russia are also experiencing rapid growth due to recognition of this technology as well as increased middle class population is these countries, which are also increasing the demand for advanced medical devices. The key Players include Olympus, Pentax, FUJIFILM Holdings, Stryker, Hoya, HMB Endoscopy Products, Cook Medical Shanghail AOHUA, Bostan Scientific, and Advanced Endoscopy Devices. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/pharmaceuticals-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ Visit our Blog: hexaresearch1.blogspot.com The Global Medical Nonwoven Disposables Market is projected to expand at a CAGR surpassing 7.9% during the forecast period (2014 to 2020). The industry stood at USD 5980 million in 2013. Booming global population and rising cases of incontinence & related disorders are key market drivers. Other factors that fuel demand are surging income levels, sophisticated medical infrastructure, and high incidence of hospital acquired infections.
Medical nonwoven disposables are made of special nonwoven materials that prevent cross contaminations. They effectively sieve out bacteria that spread infections. Medical nonwoven disposables are preferred over conventional textiles since the former exhibit greater protection against infections. One of its key demand drivers is the widespread acceptance of the same among medical practitioners. The global medical nonwoven disposables market is categorized on the basis of products and regions. The product portfolio comprises disposable nonwoven hygiene products and nonwoven medical supplies. In 2013, the industry was dominated by the nonwoven medical supplies segment. It accounts for more than 50% of total revenues. The market for hygiene products is anticipated to expand robustly over the forecast period. High adoption rate and rising cases of urinary & fecal incontinence propel demand for hygiene products. Browse Details of Report@ https://www.hexaresearch.com/research-report/medical-nonwoven-disposables The disposable incontinence pads & ostomy liners segment led the disposable nonwoven sanitation products industry in 2013. These products are essentially used in light or medium incontinence cases. It is expected that the introduction of eco-friendly & chlorine free incontinence pads will significantly contribute to market demand. Geographically, the worldwide medical nonwoven disposables market is categorized into four key segments: Europe, North America, Asia Pacific, and Rest of the World. Owing to high patient awareness, intense R&D activities, and the presence of updated technologies, North America dominated the global market in 2013. This region receives immense government support. According to recent surveys, disposable adult incontinence products are needed by nearly 29 million individuals in North America. Such a trend could further fuel regional demand during the forecast period. China and India are the two main Asia Pacific economies that are poised to witness remarkable growth in the forthcoming years. Regional market drivers are widespread awareness about hospital acquired infections and surging healthcare expenditure. Prominent industry players are Kimberly Clark Corporation, Svenska Cellulosa Aktiebolaget (SCA), Unicharm Corporation, Covidien, and Freudenberg Nonwovens among many others. Characterized by stiff competition, the global industry thrives on new product development and innovations. Biodegradable & gender specific diapers are expected to positively impact the market in the long run. Currently, the industry is witnessing high demand for nonwovens that are meant for moderate & heavy incontinence. These products include pull up pants and protective adult underwear. Manufacturers need to ensure that these products rank high on softness, stretchability, and strength. FIBRELLA Lite nonwoven is the award winning product manufactured by Suominen, a Finland based manufacturer of nonwovens. It is a lightweight spunlace nonwoven that is widely available and is employed in adult incontinence & baby care applications. This material employs excellent bonding, finishing, and forming technologies. Introduction of this product has enabled Suominen to expand its customer base considerably. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-it-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ Visit Our Blog - hexaresearch1.blogspot.com The global Healthcare Nanotechnology Market is anticipated to grow at a CAGR surpassing 12% from 2016 to 2024 (forecast period). This market is primarily driven by technological advancements & innovations in nanotechnology. Nanotechnology in healthcare aims at curing molecular & submicroscopic parts by monitoring & repairing, and by reconstructing them. This industry is propelled by development initiatives that are funded by government & private organizations that focus on neurological & cardiovascular ailments. Focus on enhancing drug efficiency also has a favorable impact on market demand. Nanotechnology is expected to gain importance in the areas of disease prevention, diagnosis, and therapy.
The global healthcare nanotechnology market is segmented on the basis of applications, end users, and regions. On the basis of applications, the industry is categorized into clinical cardiology, drug delivery systems, clinical neurology, molecular diagnostics, clinical oncology, and anti-inflammatory & anti-infective applications. The other applications are kidney andophthalmology, dental, hematology, and orthopedic. Clinical oncology is a rapidly growing segment due to the efficacy of nano particles to fight against cancerous tissues & tumors. Browse Details of Report @ https://www.hexaresearch.com/research-report/healthcare-nanotechnology-industry High incidence of cardiovascular anomalies can augment the cardiovascular segment over the forecast period. The market for nanotechnology applications in cardiology holds high growth potential in most developing & underdeveloped economies. The anti-infective segment is projected to expand considerably because of rising prevalence of air-borne diseases, bird flu, and swine flu. Based on end users, the market is trifurcated into ambulatories, clinics, and hospitals. The hospitals segment may expand substantially owing to rising cases of chronic ailments and high awareness about disease prevention. A number of large and medium sized hospitals have begun adopting nanotechnology. Unlike small hospitals that have limited resources, the large ones can adopt newer technologies because of favorable budgetary conditions. Geographically, the global industry is divided into Asia Pacific, North America, Europe, and Rest of the World. North America held the highest share in terms of revenue in 2014. Factors, such as high investments and sophisticated technologies can fuel this region in the forthcoming years. Ongoing industry trends suggest that Asia Pacific may register a high rate of growth at the same time. Key regional drivers are surging disposable incomes, outsourcing of healthcare services, and growing population. Prominent companies operating in the worldwide healthcare nanotechnology market are Celgene Corporation, CombiMatrix Corporation, Johnson & Johnson, Abbott Laboratories, and Teva Pharmaceuticals Industries Ltd. Characterized by stiff competition, the industry witnesses frequent business ventures and regional expansion initiatives. Researchers & scientists are trying to develop nanosensors that can detect the occurrence of heart attacks (myocardial infarction). This could not only save lives but also money. Such a technology uses miniature blood stream nanosensors chips that can sense the onset of a heart attack. An individual with the help of this tiny chip can receive a warning on some wireless device or smartphone to immediately seek medical help. The updated version of this chip measures only ninety microns (a size way lesser than a sand grain). This combination of a smartphone and a nanosensor may even help detect certain types of cancers and autoimmune diseases. These sensors are mostly used in animals for glucose detection. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/biotechnology-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ Visit our Blog: hexaresearch1.blogspot.com Polio vaccines are the vaccines that are employed to avert the rates of poliomyelitis. Two kinds of polio vaccines are available. The first one deploys inactivated poliovirus and is offered via injection and the other one utilizes weakened poliovirus which is offered through mouth. It has been found that it is quite secure to use the inactivated polio vaccines. At times what happens, at the site of injection, mild redness or pain occurs.
On the contrary, the oral polio vaccines lead to vaccine-associated paralytic poliomyelitis in about three per million doses. It has been observed that the chances for a person to get paralyze after a polio infection are quite few. However, both are generally considered as safe to give at the time of pregnancy and to those who have HIV/AIDS. Recommendations by World Health Organization states that all the children around the world should be vaccinated against polio. It is said that these two categories of vaccines have contributed largely in eradicating polio from majority of the parts in the world that has in turn decreased the number of cases. Market size on the basis of application spans Pediatric, and Adult. Among both of them, the pediatrics segment is likely to obtain the largest share in the market, the reason being increase in the number of awareness programs for raising awareness regarding vaccination. Browse Details of Report @ https://www.hexaresearch.com/research-report/polio-vaccines-market Market size on the basis of geography spans North America, China, Europe, Japan, India, and Southeast Asia. As far as the geography is concerned, North American is currently leading the market, the reason being initiatives laid down by the government for encouraging the adoption of immunization against diseases like influenza and HPV. Target Audience of the global polio vaccines market include Vaccine Manufacturers, Clinical Laboratories, Vaccine Associations, Vaccine Research Institutes, Group Purchasing Organizations (GPOs), Vaccine Raw Material Suppliers, Immunization Centers, Research and Consulting Firms, Vaccine Product Distributors, Vaccine Development Institutes and Organizations, Hospitals and Laboratories, and Biotechnology and Biopharmaceutical Companies. Major companies operating in the global polio vaccines market include Emergent BioSolutions, Inc, Astellas Pharma Inc, CSL Limited, GlaxoSmithKline, Johnson & Johnson, MedImmune, LLC, Merck & Co, Pfizer, Sanofi Pasteur, and Serum Institute India Pvt. Ltd. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/pharmaceuticals-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ Visit Our Blog - hexaresearch1.blogspot.com |
Archives
October 2023
|